2-(3-氟苯基)-吡咯烷 | 298690-72-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 2-(3-氟苯基)-吡咯烷
• 中文别名: 2-(3-氟苯基)吡咯；2-(3-氟苯基)吡咯烷
• 英文名称: 2-(3-fluorophenyl)pyrrolidine
• CAS: 298690-72-9
• 化学式: C₁₀H₁₂FN
• mdl: MFCD02663475
• 分子量: 165.21
• InChiKey: OADZVVBVXBBMPW-UHFFFAOYSA-N

物化性质

• 沸点：
  232.3±33.0 °C(Predicted)
• 密度：
  1.078±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H227,H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(3-Fluorophenyl)pyrrolidine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(3-Fluorophenyl)pyrrolidine
CAS number: 298690-72-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H12FN
Molecular weight: 165.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(3-氟苯基)-吡咯烷 在 potassium fluoride 、 potassium hydroxide 作用下， 以 乙醇 、 二甲基亚砜 为溶剂， 反应 25.0h， 生成 6-(2-(3-fluorophenyl)pyrrolidin-1-yl)imidazo[1,2-b]pyridazine-3-carboxylic acid
  参考文献：
  名称：

  开发亚纳摩尔级放射性氟化（2-吡咯烷-1-基）咪唑并[1,2 - b ]哒嗪pan-Trk抑制剂作为PET成像探针†

  摘要：

  原肌球蛋白受体激酶（TrkA / B / C）表达和信号传导失调被认为是许多神经退行性疾病的标志，包括帕金森氏病，亨廷顿氏病和阿尔茨海默氏病。已知TrkA / B / C可在多种神经源性和非神经源性人类癌症中驱动肿瘤发生和转移潜力。合适的正电子发射断层扫描（PET）放射性配体的开发将允许在体内探索这种多功能的潜在治疗靶标。在此，对6-（2-（3-氟苯基）吡咯烷-1-基）咪唑并[1,2 - b ]哒嗪-3-酰胺铅结构的酰胺部分进行合理重塑，以适应有效的氟18标记铅皮摩尔IC 50鉴定一系列氟化Trk抑制剂。随后的代表性放射性标记抑制剂[ 18 F] 16（[ 18 F]-（±）-IPMICF6）和[ 18 F] 27（[ 18 F]-（±）-IPMICF10）构成了新型的约2至3的先导放射性配体-与以前的铅示踪剂相比，TrkB / C效能提高了几个数量级，并显示出了良好的选择性和物理化学参数，可转化为体内PET显像剂。

  DOI：

  10.1039/c5md00388a
• 作为产物：
  描述：

  间氟苯甲酸 在 盐酸 、 sodium tetrahydroborate 、 氯化亚砜 、 sodium hydride 、 溶剂黄146 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 18.0h， 生成 2-(3-氟苯基)-吡咯烷
  参考文献：
  名称：

  N-羟基-氨基苄氧基芳基酰胺类似物作为新型选择性κ阿片受体拮抗剂的设计，合成和生物学评估。

  摘要：

  设计并合成了氨基苄氧基芳基酰胺衍生物1a-i和2a-t作为新型选择性κ阿片受体（KOR）拮抗剂。将LY2456302的苯甲酰胺基部分改为N-羟基苯甲酰胺和苯并异恶唑-3（2H）-一，以研究其是否可以增加对KOR的结合亲和力或选择性。在放射性配体结合试验中评估了所有目标化合物的阿片受体结合亲和力。这些努力导致鉴定出对KOR具有高亲和力的化合物1c（κKi = 179.9 nM）。此外，与（±）LY2456302相比，KOR对MOR和DOR的选择性分别增加了近2倍和7倍。

  DOI：

  10.1016/j.bmcl.2020.127236

文献信息

• COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS
  申请人：Fan Yi

  公开号：US20120065184A1

  公开（公告）日：2012-03-15

  The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity.

  该发明提供了化合物、包含该化合物的药物组合物以及使用该化合物治疗或预防与TRK激酶活性异常或失调相关的疾病或病症的方法。
• [EN] COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS<br/>[FR] COMPOSÉS ET COMPOSITIONS COMME INHIBITEURS DE TRK
  申请人：IRM LLC

  公开号：WO2012034095A1

  公开（公告）日：2012-03-15

  The invention provides compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity. wherein: and the rest of the variables are as specified in the claims.

  本发明提供了公式(I)的化合物，包含此类化合物的药物组合物以及使用此类化合物治疗或预防与异常或失调的TRK激酶活性相关疾病或失调的方法。其中：其余变量如权利要求中所述。
• [EN] (DIHYDRO)PYRROLO[2,1-A]ISOQUINOLINES<br/>[FR] (DIHYDRO)PYRROLO[2,1-?]ISOQUINOLINES
  申请人：ORGANON NV

  公开号：WO2009098283A1

  公开（公告）日：2009-08-13

  The invention relates to 5,6 - dihydropyrrolo [2,1-a] isoquinoline and pyrrolo[2,1-a] isoquinoline derivatives according to general formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of infertility.

  这项发明涉及根据通式（I）制备的5,6-二氢吡咯并[2,1-a]异喹啉和吡咯并[2,1-a]异喹啉衍生物，或其药学上可接受的盐。这些化合物可用于治疗不孕症。
• [EN] SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS<br/>[FR] COMPOSÉS PYRAZOLO[1,5-A]PYRIMIDINES SUBSTITUÉES EN TANT QU'INHIBITEURS DES TRK KINASES
  申请人：ARRAY BIOPHARMA INC

  公开号：WO2011006074A1

  公开（公告）日：2011-01-13

  Compounds of Formula (I) and salts thereof in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.

  式（I）的化合物及其盐，其中R1、R2、R3、R4、X、Y和n的含义如规范中所述，是Trk激酶的抑制剂，并且在治疗可以用Trk激酶抑制剂治疗的疾病中具有用处，如疼痛、癌症、炎症、神经退行性疾病和某些传染病。
• Hydrogen bond directed aerobic oxidation of amines <i>via</i> photoredox catalysis
  作者：Hongyu Wang、Yunquan Man、Kaiye Wang、Xiuyan Wan、Lili Tong、Na Li、Bo Tang

  DOI：10.1039/c8cc06603e

  日期：——

  An application of H-bonding interactions for directing the α-C–H oxidation of amines to amides and amino-ketones catalyzed by an organic photocatalyst is reported. The high efficiency of this method is demonstrated by the aerobic oxidation of pyrrolidines, diarylamines and benzylamines bearing urea groups with high yields and a wide substrate scope.

  据报道，在有机光催化剂的催化下，H键相互作用可指导胺的α-C–H氧化为酰胺和氨基酮。带有脲基团的吡咯烷，二芳基胺和苄基胺的好氧氧化具有高收率和广泛的底物范围，证明了该方法的高效率。